Fig. 1From: CD33 splice site genotype was not associated with outcomes of patients receiving the anti-CD33 drug conjugate SGN-CD33ANo difference in outcome according to CD33 splice site genotype for patients receiving SGN-CD33A. Kaplan-Meier survival estimates for a overall survival and b event-free survivalBack to article page